• HOME
• JOIN CHE
  • Why Join CHE?
  • How to Participate
  • Application to Join
• ABOUT CHE
  • Mission
  • CHE Consensus Statement
  • History
  • What Our Partners Say
  • Staff Information
  • CHE Partner Directory
• NEWS AND EVENTS
  • Partnership Calls
  • Working Group Calls
  • Conferences
  • News Feed/
    Announcements
  • CHE Newsletter
  • Searchable Calendar
• INITIATIVES
  • Working Groups
    • Breast Cancer
    • Cancer
    • Children's Environmental Health / ICEH
    • Cumulative Impacts
    • Diabetes-Obesity Spectrum
    • Electromagnetic Fields
    • Fertility / Repro Health
    • Healthy Aging
    • LDDI/Developmental Disabilities
  • Listservs
    • Asthma
    • Autism
    • Climate Change
    • Integrative Health
    • Mental Health
    • Neurodegenerative Diseases
    • Pet
    • Science
    • Science Database
  • State-based Working Groups
    • Alaska
    • Oregon
    • Washington State
  • Environmental Health Trainings
• RESOURCES
  • Toxics Database
  • CHE Consensus Statements
  • Portal to Science
  • Chemical Policy Reform
  • President's Cancer Panel
  • Reports, Policies and Other Documents
  • Resolutions and Scientific Statements from Other Organizations
  • Practice Prevention and Fact Sheets
  • Diseases & Disorders:Analyses and Initiatives
  • CHE Blog
  • Science and Community Action
  • Translations of CHE Materials
  • Partnership Call Archive
  • Additional Resources
  • Book Reviews
• DONATE NOW

last updated in 2003 

Achanzar W, Diwan B, Liu J, et al. 2001. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res 61(2):455-458.

Adams J, Leav I, Lau K, et al. 2002. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. Prostate 52(1):69-81. Recent studies of human tissue show that alpha and beta estrogen receptors are normally present, though the beta receptor is exclusively present in epithelial cells.

Agency for Toxics Substances and Disease Registry. 1997. Toxicological profile for cadmium. (update). US Dept of Human Services.

Ahluwalia B, Jackson M, Jones G, et al. 1981. Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations. Cancer 48(10):2267-2273.

Alloway B, Jackson A. 1991. The behaviour of heavy metals in sewage sludge-amended soils. Sci Total Environ 100:151-176.

Alavanja, MCR, C Samanic, M Dosemecil, J Lubin, R Tarone, CF Lynch, C Knott, K Thomas, JA Hoppin, J Barker, J Coble, DP Sandler and A Blair. 2003. Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort. American Journal of Epidemiology 157:800–814.

Angwafo F. 1998. Migration and prostate cancer: an international perspective. J Natl Med Assoc 90(11 Suppl):S72-723.

Birnbaum LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect. 2003 Apr;111(4):389-94.

Brown, N, P Manzolillo and J Zang et al. 1998. Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 19(9):1623-1629.

Brys M, Nawrocka A, Miekos E, et al. 1997. Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Elem Res 59(1-3):145-152.

Carter H, Piantados S, Isaacs J. 1990. Clinical evidence for the implications of the multistep development of prostate cancer. J Urol 143:742-746.

Chu K, R Tarone and H Freeman. 2003. Trends in prostate cancer mortality among black men and white men in the United States. Cancer 97(6):1507-1516.

Clegg, LX, EJ Feuer, DN Midthune, MP Fay and BF Hankey. 2002. Impact of reporting delay and reporting error on cancer incidence rates and trends. Journal of the National Cancer Institute 94:1537–45.

Coffey D. 2001. Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology 57(suppl 1):31-38.

Colborn T, Clement C. 1992. Chemically-induced alternations in sexual and functional development: the wildlife/human connection. Eds:Princeton:Princeton Scientific Publ. Co.

Colborn T, Dumanoski D, Myers JP. 1996. Our stolen future. New York:Dutton.

Dich J, Wiklund K. 1998. Prostate cancer in pesticide applicators in Swedish agriculture. Prostate 34(2):100-112.

Driscoll S, Taylor S. 1980. Effects of prenatal maternal estrogen on the male urogenital system. Obstet Gynecol 56(5):537-542.

Dunn J. 1975. Cancer epidemiology in populations of the United States—with emphasis on Hawaii and California—and Japan. Cancer Res 35:3240-3245.

Fleming L, Bean J, Rudolph M, Hamilton K. 1999. Cancer incidence in a cohort of licensed pesticide applicators in Florida. J Occup Environ Med 41(4):279-288.

Fleming L, Bean J, Rudolph M, Hamilton K. 1999. Mortality in a cohort of licensed pesticide applicators in Florida. Occup Environ Med 56(1):14-21.

Fritz W, Wang J, Eltoum I, Lamartiniere C. 2002. Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol 186(1):89-99.

Gann P, Hennekens M, Sacks F, et al. 1994. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Canc Inst 86:281-286.

Giovannucci E, Rimm E, Colditz G, et al. 1993. A prospective study of dietary fat and risk of prostate cancer. J Natl Canc Inst 85:1571-1579.

Gupta C. 2000. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exp Biol Med 224(2):61-68.

Habermann H, Chang W, Birch L, et al. 2001. Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate. Endocrinol 142(1):359-369.

Haenzel W, Kurihara M. 1968. Studies of Japanese migrants, I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Canc Inst 40:43-68.

Hill P, Wynder E, Garbaczewski L, Walker A. 1982. Effect of diet on plasma and urinary hormones in South African black men with prostate cancer. Cancer Res 42(9):3864-3869.

Jannulis L, Grayhack J, Lee C. 2000. Endocrinology of the prostate. In: Prostatic Diseases. Ed: Lepor H. WB Saunders Philadelphia.

Janssens J, Van Hecke E, Geys H, et al. 2001. Pesticides and mortality from hormone-dependent cancers. Eur J Cancer Prev 10(5):459-467.

Keller-Byrne J, Khuder S, Schaub E. 1997. Meta-analysis of prostate cancer and farming. Am J Ind Med 31(5):580-586.

Kolonel L. 1996. Nutrition and prostate cancer. Cancer Causes and Control 7:83-94.

Kross B, Burmeister L, Ogilvie L, et al. 1996. Proportionate mortality study of golf course superintendents. Am J Ind Med. 29(5):501-506.

Lange P. 1994. Future studies in localized prostate cancer. What should we think? What can we do? J Urol 152:1932-1938.

Lichtenstein P, Holm N, Verkasalo P, et al. 2000. Environmental and heritable factors in the causation of cancer. New England Journal of Medicine 343:78-85.

Lin D, Lange P. 2000. The epidemiology and natural history of prostate cancer. In: Prostatic Diseases. Ed: Lepor H. WB Saunders Philadelphia.

Michaud D, K Augustsson and E Rimm et al. 2001. A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes and Control 12:557-567, 2001

Mills P. 1998. Correlation analysis of pesticide use data and cancer incidence rates in California counties. Arch Environ Health. 53(6):410-413.

Nagata C, Tagatsuka N, Shimizu H, et al. 2001. Effect of soymilk consumption on serum estrogen and androgen concentrations in Japanese men. Cancer Epidemiol Biomarkers Prev 10(3):179-184.

Nagel S, vom Saal F, Thayer K, et al. 1997. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environmental Health Perspectives 105(1):7076.

Naslund M, Coffey D. 1986. The differential effects of neonatal androgen, estrogen, and progesterone on adult rat prostate growth. J Urol 136(5):1136-1140.

National Research Council. 1999. Hormally active agents in the environment. National Academy Press. Washington DC.

Nelson C, L Kidd and J Sauvageot et al. 2001. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res 61(1):103-109.

Osegbe D. 1997. Prostate cancer in Nigerians: facts and nonfacts. J Urol 157(4):1340-1343.

Piscator M. 1985. Dietary exposure to cadmium and health effects: impact of environmental changes. Environmental Health Perspectives 63, 127-132.

Ralph JL, Orgebin-Crist MC, Lareyre JJ, Nelson CC. Disruption of androgen regulation in the prostate by the environmental contaminant hexachlorobenzene. Environ Health Perspect. 2003 Apr;111(4):461-6.

Ramos J, Varayoud J, Sonnenschein C, et al. 2001. Prenatal exposure to low doses of bisphenol A alters the periductal stroma and glandular cell function in the rat ventral prostate. Biol Repro 65:1271-1277.

Rose D, Boyar A, Wynder E. 1986. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon and per capita food consumption. Cancer 58:2363-2371.

Rosen E, Fan S, Goldberg I. 2001. BRAC1 and prostate cancer. Cancer Invest 19(4):396-412.

Sakr W, Haas G, Cassin B. 1993. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150:379-385.

Sakr W, D Grignon and J Crissman et al. 1994. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 8(3):439-443, 1994.

Santti R, Newbold R, Makela S, et al. 1994. Developmental estrogenization and prostatic neoplasia. Prostate 24(2):67-78.

Saroff J, Kirdani R, Chu T, et al. 1980. Measurements of prolactin and androgens in patients with prostatic diseases. Oncology 37:46.

Schettler T, Solomon G, Valenti M, Huddle A. 1999. Generations at risk: reproductive health and the environment. Cambridge:MIT Press.

Shapiro E. 2000. The embryology and development of the prostate. In: Prostatic Diseases. Ed: Lepor H. WB Saunders Philadelphia.

Sharma-Wagner S, Chokkalingam A, Malker H, et al. 2000. Occupation and prostate cancer risk in Sweden. J Occup Environ Med 42(5):517-525.

Shimizu H, Ross R, Bernstein L, et al. 1991. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county. Br J Cancer 63(6):963-966.

Shiraishi T, Watanabe M, Matsuura H, et al. 1994. The frequency of latent prostatic carcinoma in young males: the Japanese experience. In Vivo 8(3):445-447.

Steinberg G, Carter B, Beaty T, et al. 1990. Family history and the risk of prostate cancer. Prostate 17:337-347.

Steinmetz R, Brown N, Allen D, et al. 1997. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology 138:1780-1786.

Tessier D, Matsumura F. 2001. Increased ErbB-2 tyrosine kinase activity, MAPK phosphorylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicol Sci 60(1):38-43.

Waalkes M, Anver M, Diwan B. 1999. Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) rat: induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate, and testes. J Toxicol Environ Health A 58(4):199-214.

Waalkes M, Rehm S. 1994. Cadmium and prostate cancer. J Toxicol Environ Health 43(3):251-269.

Waalkes M. 2000. Cadmium carcinogenesis in review. J Inorg Biochem 79(1-4):241-244.

West D, Slattery M, Robinson L, et al. 1991. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85-94.

Wetherill Y, Petre C, Monk K, et al. 2002. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells. Molecular Canc Therapeut 1(7):515-524.

Yatani R, Shiraishi T, Nakakuki K, Kusano I, et al. 1988. Trends in the frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986. J Natl Cancer Inst 80(9):683-687.

van der Gulden J, Kolk J, Verbeek A. 1995. Work environment and prostate cancer risk. Prostate 27(5):250-257.

vom Saal F, Timms B, Montano M, et al. 1997. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci 94(5):2056-2061.

Wetherill, YB, CE Petre, KR Monk, A Puga, and KE Knudsen. 2002. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells. Molecular Cancer Therapeutics 1: 515–524.